A novel intraperitoneal cefepime regime based on pharmacokinetic modeling to treat CAPD peritonitis.

Yuen SK; Yuen YP; Fok SP; Yong SP; Tse MW; Chan AY

首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >A novel intraperitoneal cefepime regime based on pharmacokinetic modeling to treat CAPD peritonitis.

【24h】

A novel intraperitoneal cefepime regime based on pharmacokinetic modeling to treat CAPD peritonitis.

机译：基于药代动力学模型的新型腹膜内头孢吡肟治疗CAPD腹膜炎的方法。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Cefepimeis an ideal choice as empirical monotherapy for continuous ambulatory peritoneal dialysis (CAPD) peritonitis (1). We determined the pharmacokinetic profile of patients being treated with intra peritonea I (IP) cefepime and derived a pharmacokinetic model that could predict a drug profile when different doses of cefepime are used.

机译：Cefepimeis是连续性非卧床腹膜透析（CAPD）腹膜炎经验性单一疗法的理想选择（1）。我们确定了接受腹膜内I（IP）头孢吡肟治疗的患者的药代动力学特征，并推导出了可以预测当使用不同剂量的头孢吡肟时药物特征的药代动力学模型。

著录项

来源
《Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis》 |2010年第6期|共2页
作者
Yuen SK; Yuen YP; Fok SP; Yong SP; Tse MW; Chan AY;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. A novel intraperitoneal cefepime regime based on pharmacokinetic modeling to treat CAPD peritonitis. [J] . Yuen SK, Yuen YP, Fok SP, Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis . 2010,第6期

机译：基于药代动力学模型的新型腹膜内头孢吡肟治疗CAPD腹膜炎的方法。
2. A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel potassium-competitive acid blocker to treat gastric acid related diseases [J] . Lee Hyun A., Lee Kyeong-Ryoon, Jang Seong-Bok, Journal of pharmacokinetics and pharmacodynamics . 2018,第Suppla期

机译：基于生理学的药代动力学模型充分预测了YH4808的人类药代动力学谱，这是一种新型钾竞争性酸障碍物，以治疗胃酸相关疾病
3. A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel potassium-competitive acid blocker, to treat gastric acid related diseases [J] . Lee Hyun A., Lee Howard Journal of pharmacokinetics and pharmacodynamics . 2017,第Suppla期

机译：基于生理学上的药代动力学模型充分预测了YH4808的人类药代动力学谱，新型钾竞争性酸性酸阻滞剂，以治疗胃酸相关疾病
4. Pharmacokinetic Modeling to Improve the Design of Intravitreal Corticosteroid Implants for Treating Macular Edema [C] . Susan S. Lee, David Z. DArgenio, Rex A. Moats, Controlled Release Society Annual Meeting and Exposition . 2007

机译：药物动力学模型可改善玻璃体皮质类固醇植入物治疗黄斑水肿的设计
5. The Effectiveness of an Evidence-based Continuous Ambulatory Peritoneal Dialysis (CAPD) Retraining Program to Reduce Peritonitis among Incident CAPD Patients [D] . Leung, Wai Yin. 2019

机译：基于证据的连续动态腹膜透析（CAPD）再培训计划的有效性降低了事件CAPD患者的腹膜炎
6. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability [O] . Thomas J Dennison, Julian C Smith, Raj K Badhan, 2017

机译：固定剂量联合口服崩解片可治疗心血管疾病：制剂体外表征和基于生理的药代动力学模型以评估生物利用度
7. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease:formulation, in vitro characterization and physiologically based pharmacokinetic modelling to assess bioavailability [O] . Dennison, Thomas J., Smith, Julian C, Badhan, Raj K., 2017

机译：固定剂量组合的口腔崩解片可治疗心血管疾病：配制，体外表征和基于生理的药代动力学模型以评估生物利用度

A novel intraperitoneal cefepime regime based on pharmacokinetic modeling to treat CAPD peritonitis.

摘要

著录项

相似文献

相关主题

期刊订阅